239 related articles for article (PubMed ID: 2211568)
21. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC
Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
Lemoine P; Rouillon F; Pouget D
Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
[TBL] [Abstract][Full Text] [Related]
23. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
Risse SC; Whitters A; Burke J; Chen S; Scurfield RM; Raskind MA
J Clin Psychiatry; 1990 May; 51(5):206-9. PubMed ID: 2335496
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
25. Switching from alprazolam to buspirone.
Bystritsky A; Pasnau RO
J Clin Psychopharmacol; 1991 Jun; 11(3):219-20. PubMed ID: 2066461
[No Abstract] [Full Text] [Related]
26. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
28. Withdrawal syndrome with gradual tapering of alprazolam.
Mellman TA; Uhde TW
Am J Psychiatry; 1986 Nov; 143(11):1464-6. PubMed ID: 3535544
[TBL] [Abstract][Full Text] [Related]
29. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.
Simeon JG; Ferguson HB; Knott V; Roberts N; Gauthier B; Dubois C; Wiggins D
J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):29-33. PubMed ID: 1537778
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL
Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
Lee ST; Park JH; Kim M
Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
[TBL] [Abstract][Full Text] [Related]
32. Alprazolam in the treatment of neurotic anxiety.
Kerry RJ; McDermott CM
Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
[TBL] [Abstract][Full Text] [Related]
33. Alprazolam treatment for panic disorder.
Miller F
J Clin Psychiatry; 1987 Jul; 48(7):301. PubMed ID: 3597336
[No Abstract] [Full Text] [Related]
34. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.
Tollefson GD; Lancaster SP; Montague-Clouse J
Psychopharmacol Bull; 1991; 27(2):163-70. PubMed ID: 1924664
[TBL] [Abstract][Full Text] [Related]
35. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.
Robinson D; Napoliello MJ; Schenk J
Clin Ther; 1988; 10(6):740-6. PubMed ID: 3219687
[TBL] [Abstract][Full Text] [Related]
36. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Klein E; Colin V; Stolk J; Lenox RH
Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Jonas JM; Cohon MS
J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
[TBL] [Abstract][Full Text] [Related]
38. Buspirone in depressed outpatients: a controlled study.
Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
Psychopharmacol Bull; 1990; 26(2):163-7. PubMed ID: 2236452
[TBL] [Abstract][Full Text] [Related]
39. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Hoehn-Saric R; McLeod DR; Zimmerli WD
J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
